Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 2
Earnings before taxes -50,252 More Arrow -44,054 More Arrow -40,726
EBITDA -50,480 More Arrow -44,176 More Arrow -40,724
Total assets 19,036 More Arrow 26,763 More Arrow 36,679
Current assets 17,381 More Arrow 24,915 More Arrow 33,650
Current liabilities 5,323 More Arrow 7,949 Less Arrow 6,526
Equity capital 13,713 More Arrow 18,814 More Arrow 30,153
- share capital 8,821 Less Arrow 5,736 Less Arrow 2,557
Employees (average) 4 Equal arrow 4 More Arrow 5

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 72.0% Less Arrow 70.3% More Arrow 82.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -264.0% More Arrow -164.6% More Arrow -111.0%
Current ratio 326.5% Less Arrow 313.4% More Arrow 515.6%
Return on equity (ROE) -366.5% More Arrow -234.2% More Arrow -135.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -1 More Arrow 0
Chg. No. of employees % 0% Less Arrow -20% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.